These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 35137195)

  • 1. Parathyroid hormone and phosphate homeostasis in patients with Bartter and Gitelman syndrome: an international cross-sectional study.
    Verploegen MFA; Vargas-Poussou R; Walsh SB; Alpay H; Amouzegar A; Ariceta G; Atmis B; Bacchetta J; Bárány P; Baron S; Bayrakci US; Belge H; Besouw M; Blanchard A; Bökenkamp A; Boyer O; Burgmaier K; Calò LA; Decramer S; Devuyst O; van Dyck M; Ferraro PM; Fila M; Francisco T; Ghiggeri GM; Gondra L; Guarino S; Hooman N; Hoorn EJ; Houillier P; Kamperis K; Kari JA; Konrad M; Levtchenko E; Lucchetti L; Lugani F; Marzuillo P; Mohidin B; Neuhaus TJ; Osman A; Papizh S; Perelló M; Rookmaaker MB; Conti VS; Santos F; Sawaf G; Serdaroglu E; Szczepanska M; Taroni F; Topaloglu R; Trepiccione F; Vidal E; Wan ER; Weber L; Yildirim ZY; Yüksel S; Zlatanova G; Bockenhauer D; Emma F; Nijenhuis T
    Nephrol Dial Transplant; 2022 Nov; 37(12):2474-2486. PubMed ID: 35137195
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phosphate homeostasis in Bartter syndrome: a case-control study.
    Bettinelli A; Viganò C; Provero MC; Barretta F; Albisetti A; Tedeschi S; Scicchitano B; Bianchetti MG
    Pediatr Nephrol; 2014 Nov; 29(11):2133-8. PubMed ID: 24902942
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Bartter-Gitelman syndromes].
    Blanchard A; Courand PY; Livrozet M; Vargas-Poussou R
    Nephrol Ther; 2020 Jul; 16(4):233-243. PubMed ID: 32622651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Accentuated hyperparathyroidism in type II Bartter syndrome.
    Landau D; Gurevich E; Sinai-Treiman L; Shalev H
    Pediatr Nephrol; 2016 Jul; 31(7):1085-90. PubMed ID: 26857709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Late onset Bartter syndrome: Bartter syndrome type 2 presenting with isolated nephrocalcinosis and high parathyroid hormone levels mimicking primary hyperparathyroidism.
    Yıldız G; Torun Bayram M; Çinleti T; Koç A; Soylu A; Kavukçu S
    J Pediatr Endocrinol Metab; 2022 Oct; 35(10):1298-1301. PubMed ID: 35952717
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Different roles of the RAAS affect bone metabolism in patients with primary aldosteronism, Gitelman syndrome and Bartter syndrome.
    Tang W; Chai Y; Jia H; Wang B; Liu T; Wang H; Dai C
    BMC Endocr Disord; 2022 Feb; 22(1):38. PubMed ID: 35148746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urinary exosomes in the diagnosis of Gitelman and Bartter syndromes.
    Corbetta S; Raimondo F; Tedeschi S; Syrèn ML; Rebora P; Savoia A; Baldi L; Bettinelli A; Pitto M
    Nephrol Dial Transplant; 2015 Apr; 30(4):621-30. PubMed ID: 25422309
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal phosphate handling in Gitelman syndrome--the results of a case-control study.
    Viganò C; Amoruso C; Barretta F; Minnici G; Albisetti W; Syrèn ML; Bianchetti MG; Bettinelli A
    Pediatr Nephrol; 2013 Jan; 28(1):65-70. PubMed ID: 22990302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of compound mutations of SLC12A3 gene in a Chinese pedigree with Gitelman syndrome exhibiting Bartter syndrome-liked phenotypes.
    Dong B; Chen Y; Liu X; Wang Y; Wang F; Zhao Y; Sun X; Zhao W
    BMC Nephrol; 2020 Aug; 21(1):328. PubMed ID: 32758178
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating parathyroid hormone activity: familial hypocalciuric hypercalcemia versus typical primary hyperparathyroidism.
    Marx SJ; Spiegel AM; Brown EM; Windeck R; Gardner DG; Downs RW; Attie M; Aurbach GD
    J Clin Endocrinol Metab; 1978 Dec; 47(6):1190-7. PubMed ID: 233692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of parathyroid hormone and 1,25-dihydroxyvitamin D3 on tubular handling of phosphate in hypophosphatemic rickets.
    Alon U; Chan JC
    J Clin Endocrinol Metab; 1984 Apr; 58(4):671-5. PubMed ID: 6546575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced phosphate reabsorption unrelated to parathyroid hormone after renal transplantation: implications for the pathogenesis of hyperparathyroidism in chronic renal failure.
    Parfitt AM; Kleerekoper M; Cruz C
    Miner Electrolyte Metab; 1986; 12(5-6):356-62. PubMed ID: 3543637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fibroblast growth factor 23, but not parathyroid hormone, is associated with urinary phosphate regulation in patients on peritoneal dialysis.
    Yamada S; Tsuruya K; Tokumoto M; Yoshida H; Hasegawa S; Tanaka S; Eriguchi M; Nakano T; Masutani K; Ooboshi H; Kitazono T
    Ther Apher Dial; 2015 Feb; 19(1):73-80. PubMed ID: 25195562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bartter and Gitelman syndromes.
    Zieg J; Doležel Z
    Cas Lek Cesk; 2022; 161(3-4):131-134. PubMed ID: 36100451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Parathyroid Hormone, Fibroblast Growth Factor 23, and Parameters of Phosphate Reabsorption.
    Phelps KR; Mason DL
    Am J Nephrol; 2018; 47(5):343-351. PubMed ID: 29779023
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bartter Syndrome and Gitelman Syndrome.
    Fulchiero R; Seo-Mayer P
    Pediatr Clin North Am; 2019 Feb; 66(1):121-134. PubMed ID: 30454738
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fibroblast growth factor-23 in early chronic kidney disease: additional support in favor of a phosphate-centric paradigm for the pathogenesis of secondary hyperparathyroidism.
    Evenepoel P; Meijers B; Viaene L; Bammens B; Claes K; Kuypers D; Vanderschueren D; Vanrenterghem Y
    Clin J Am Soc Nephrol; 2010 Jul; 5(7):1268-76. PubMed ID: 20448073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular Basis, Diagnostic Challenges and Therapeutic Approaches of Bartter and Gitelman Syndromes: A Primer for Clinicians.
    Nuñez-Gonzalez L; Carrera N; Garcia-Gonzalez MA
    Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34768847
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Calcium clamp technique: suppression of serum intact PTH by induced hypercalcaemia in normal man and primary hyperparathyroidism.
    Sørensen HA; Schwarz P; McNair P; Hyldstrup L; Transbøl I
    Scand J Clin Lab Invest; 1992 Oct; 52(6):457-65. PubMed ID: 1411258
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.